Harvard Scientific obtains patent covering PGE-1 lyophilized liposomes
Additionally, Harvard Scientific's delivery system continues to impress industry professionals. Joseph Williams MD, Board Certified Urologist states, "Harvard Scientific's proprietary delivery system is painless, and thus has an opportunity to revolutionize the future treatment of male erectile dysfunction."
Harvard Scientific is a biopharmaceutical company that is developing products relating the lyophilized liposomal delivery of Prostaglandin E-1 for treating male erectile dysfunction and impotency. The company has completely its Phase I clinical trials and is moving ahead to complete Phase II/III.
|Printer friendly Cite/link Email Feedback|
|Publication:||BIOTECH Patent News|
|Date:||Aug 1, 1997|
|Previous Article:||Nycomed Amersham remains confident of strong ultrasound patent position|
|Next Article:||Biodynamics Pharmaceuticals receives United States patent for method of controlling and treating adverse inflammatory reactions|